Cancer Biomarkers and Precision Oncology: A Review of Recent Trends and Innovations
View abstract on PubMed
Summary
This summary is machine-generated.Cancer biomarkers improve diagnostics and treatments, leading to better patient outcomes. This review covers recent Middle Eastern advances in biomarkers, immunotherapy, AI, and pharmacogenomics for precision cancer care.
Area Of Science
- Oncology
- Biomarker Discovery
- Precision Medicine
Background
- Cancer biomarkers are crucial for diagnostics and therapeutics, reducing morbidity and mortality.
- Biomarkers are classified as prognostic (predicting outcomes) or predictive (predicting treatment response).
- Advancements in predictive biomarkers are driving the integration of precision medicine in cancer care.
Purpose Of The Study
- To provide an overview of recent advancements in cancer biomarkers.
- To highlight progress in immunotherapy, artificial intelligence, and pharmacogenomics.
- To focus on developments within the Middle East region.
Main Methods
- Literature review of recent scientific publications.
- Synthesis of information on cancer biomarkers, immunotherapy, AI, and pharmacogenomics.
- Focus on research originating from or relevant to the Middle East.
Main Results
- Significant progress has been made in identifying and utilizing cancer-specific biomarkers.
- Immunotherapy, artificial intelligence, and pharmacogenomics are increasingly important in cancer research.
- The Middle East shows growing contributions and engagement in these advanced cancer research areas.
Conclusions
- Cancer biomarkers are pivotal in advancing cancer diagnostics and treatment strategies.
- The integration of immunotherapy, AI, and pharmacogenomics, guided by biomarkers, enhances precision medicine.
- Continued research in the Middle East is vital for global advancements in oncology.
Related Concept Videos
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...

